Inventor · disambiguated record
Kathleen Z. Reape
Also filed as: REAPE KATHLEEN · REAPE KATHLEEN Z
5 granted patents·5 pending applications·72 citations·filing 2004–2012
78Inventor score
Top patents by PatentIndex Score
10 records- 0192US8415332B2Methods of hormonal treatment utilizing ascending-dose extended cycle regimensDILIBERTI CHARLES E·Filed 2007·Granted Apr 9, 2013·53 cites·18 claims
- 0276US7855190B2Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administrationTEVA WOMENS HEALTH INC·Filed 2004·Granted Dec 21, 2010·10 cites·42 claims
- 0371US7772219B2Methods of hormonal treatment utilizing extended cycle contraceptive regimensTEVA WOMENS HEALTH INC·Filed 2004·Granted Aug 10, 2010·8 cites·7 claims
- 0467US8450299B2Methods of hormonal treatment utilizing ascending-dose extended cycle regimensDILIBERTI CHARLES E·Filed 2012·Granted May 28, 2013·1 cites·20 claims
- 0557US8288342B2Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetateAHMED SALAH U·Filed 2009·Granted Oct 16, 2012·0 cites·19 claims
- 0656US2009163454A1Methods of Step-Down Hormone TreatmentDURAMED PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 0754US2007111975A1Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle RegimensDURAMED PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 0849US2006135496A1Methods of hormonal treatment utilizing ascending-dose extended cycle regimensDURAMED PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 0942US2011124611A1Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administrationTEVA WOMENS HEALTH INC·Filed 2010·Application pending·0 cites
- 1042US2009247493A1Regimens for Treatment of Conditions Related to Estrogen DeficiencyDURAMED PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kathleen Z. Reape files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →